Max Robotics — Global Service Robot Directory + US Certification

About

Leah McNally is a leading gynecologic oncologist whose research focuses on advancing surgical approaches for advanced epithelial ovarian cancer. Her work centers on evaluating the safety and effectiveness of minimally invasive surgery (MIS) compared to traditional laparotomy, particularly in patients undergoing interval debulking after neoadjuvant chemotherapy. Her most-cited paper, "Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer" (2024, 22 citations), critically examines the feasibility of a full-scale randomized clinical trial to address the growing but unproven use of MIS in this setting. This work highlights her commitment to evidence-based practice, challenging the field to generate high-quality data before widespread adoption. In a multi-institutional study (2021), she further compared outcomes of MIS versus laparotomy, contributing foundational insights into perioperative and oncologic results. McNally’s research is pivotal for surgeons and oncologists seeking to balance the benefits of less invasive techniques with the imperative of complete cytoreduction. Her contributions are shaping the future of ovarian cancer surgery, emphasizing rigorous evaluation to improve patient outcomes.